Calcium supplementation shows a hepatoprotective effect against high-fat diet by regulating oxidative-induced inflammatory response and lipogenesis activity in male rats

10.1016/j.jtcme.2019.06.002

Sandeep Das；Dipayan Choudhuri

Obesity ； NAFLD ； Oxidative ； Antioxidant ； Inflammation

Journal of Traditional and Complementary Medicine

10卷5期（2020 / 09 / 01）

511 - 519

英文

Background and aim: High-fat diet (HFD) triggers obesity-related metabolic diseases like non-alcoholic fatty liver diseases (NAFLD). Calcium supplementation is known to have an anti-obesity effect. However, the effect of calcium supplementation has not been evaluated so far in context to hepatic functions on exposure to HFD. The goal of the present study was to investigate the role of calcium supplementation on hepatic function and other physiological markers in HFD induced NAFLD rats. Experimental procedure: 18 male Wistar rats were divided into two groups; first group considered control group (n = 6) for the entire treatment period and the second group (n = 12) fed with HFD for 6 weeks to induce NAFLD model and then sub-divided into two groups (n = 6 rats); one group received HFD and other group received 1.0 gm CaCO_3/100 gm HFD for 30 days. After treatment, all animals were euthanized to collect the blood and liver for biochemical, enzymatic, oxidative, anti-oxidant, western blot and histological study. Results and conclusion: Calcium supplementation significantly improved the anthropometric parameters and decreases the level of serum cholesterol, triglyceride, FFA and hepatic enzymes. Calcium supplementation significantly down-regulated the hepatic PPAR-γ mediated FAS activity, hepatic lipid accumulation, oxidative stress and restored the activities of antioxidant enzyme which further prevented the stimulation of pro-inflammatory response. Calcium supplementation also increases the hepatic protein expression of phosphorylated AMP-activated protein kinase. So, calcium supplementation showed a hepatoprotective effect during NAFLD by down-regulating the oxidative induced inflammatory response stimulated by hepatic lipogenesis activity and subsequent lipid accumulation.

1. Davodi, I,Rahimini, R,Abdollahi, M(2017).Promising effect of Rosa damascene extract on high-fat diet-induced nonalcoholic fatty liver.J Trad Complement Med,7,508-514.
   連結：
2. (1983).Methods of Enzymatic Analysis.
3. Aebi, H(1984).Catalase in vitro.Methods Enzymol,105,121-126.
4. Christensen, R,Lorenzen, JK,Svith, CR(2009).A Effect of calcium from dairy and dietary supplements on faecal fat excretion: a meta-analysis of randomized controlled trials.Obes Rev.,10(4),475-486.
5. Ellman, GL.(1959).Tissue sulfhydryl groups.Arch Biochem Biophys,82,70-77.
6. Fabbrini, E,Sullivan, S,Klein, S(2010).Obesity and nonalcoholic fatty liver disease: biochemical, metabolic and clinical implications.Hepatology,51(2),679-689.
7. Farzaei, MH,Zobeiri, M,Parvizi, F(2018).Curcumin in liver diseases: a systematic review of the cellular mechanisms of oxidative stress and clinical perspective.Nutrients,10,1-28.
8. Folch, J,Lees, M,Stanley, GHS(1957).A simple method for the isolation and purification of total lipids from animal tissues.J Biol Chem,226(1),497-509.
9. Gao, L,Cao, JT,Liang, Y(2015).Calcitriol attenuates cardiac remodeling and dysfunction in a murine model of polycystic ovary syndrome.Endocrine,52,363-373.
10. Garcia, PV,Seiva, FRF,Carniato, AP(2016).Increased toll-like receptors and p53 levels regulate apoptosis and angiogenesis in non-muscle invasive bladder cancer: mechanism of action of P-MAPA biological response modifier.BMC Canc,16(422),1-18.
11. Gavrilova, O,Haluzik, M,Matsusue, K(2003).Liver peroxisome proliferator-activated receptor γ contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass.J Biol Chem,278,34268-34276.
12. Green, LC,Wagner, DA,Glogowski, J(1982).Analysis of nitrate, nitrite, and [15 N] nitrate in biological fluids.Anal Biochem,126,131-138.
13. Guilherme, A,Tesz, GJ,Guntur, KVP,Czech, MP(2009).Tumor necrosis factor-α induces caspase-mediated cleavage of peroxisome proliferator-activated receptor in adipocytes.J Biol Chem,284(25),17082-17091.
14. Halestrap, AP,Denton, RM(1973).Insulin and the regulation of adipose tissue acetyl CoA carboxylase.Biochem J.,132,509-517.
15. He, YH,Li, ST,Wang, YY(2012).Postweaning low-calcium diet promotes later-life obesity induced by a high-fat diet.J Nutr Biochem,23,1238-1244.
16. Jacqmain, M,Doucet, E,Després, JP,Bouchard, C,Tremblay, A(2003).Calcium intake, body composition, and lipoprotein-lipid concentrations in adults.Am J Clin Nutr.,77,1448-1452.
17. Jung, UJ,Choi, MS(2014).Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease.Int J Mol Sci.,15,6184-6223.
18. Kakimoto, PA,Kowaltowski, AJ(2016).Effects of high fat diets on rodent liver bioenergetics and oxidative imbalance.Redox Biology,8,216-225.
19. Kesh, SB,Sarkar, D,Manna, K(2016).High-fat diet-induced oxidative stress and its impact on metabolic syndrome: a review.Asian J Pharmaceut Clin Res,9(1),47-52.
20. Lindholm, CR,Ertel, RL,Bauwens, JD,Schmuck, EG,Mulligan, JD,Saupe, KW(2013).A high-fat diet decreases AMPK activity in multiple tissues in the absence of hyperglycemia or systemic inflammation in rats.J Physiol Biochem,69,165-175.
21. Lowry, OH,Rosebrough, NJ,Farr, AL,Randall, RJ(1951).Protein measurement with the Follin phenol reagent.J Biol Chem,193,265-275.
22. Marklund, S,Marklund, G(1974).Involvement of superoxide anion radical in the antoxidation of pyrogallol: a convenient assay for superoxide dismutase.Eur J Biochem,47,469-476.
23. Meli, R,Raso, GM,Calignano, A(2014).Role of innate immune response in non-alcoholic fatty liver disease: metabolic complications and therapeutic tools.Front Immunol,5,1-14.
24. Morán-Salvador, E,López-Parra, M,García-Alonso, V(2011).Role for PPARγ in obesity-induced hepatic steatosis as determined by hepatocyte-and macro-phage-specific conditional knockouts.FASEB J.,25,2538-2550.
25. Musso, G,Gambino, R,Cassader, M(2009).Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD).Prog Lipid Res,48,1-26.
26. Noeman, SA,Hamooda, HE,Baalash, AA(2011).Biochemical study of oxidative stress markers in the liver, kidney and heart of high fat diet induced obesity in rats.Diabetol Metab Syndrome,3(17),1-8.
27. Ohkawa, H,Ohishi, N,Yagi, K(1979).Assay for lipid peroxides in animal tissues by the thiobarbituric acid reaction.Anal Biochem,95,351-358.
28. Paglia, DE,Valentine, WN(1967).Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase.J Lab Clin Med,70,158-169.
29. Park, YJ,Lee, GS,Cheon, SY,Cha, YY,An, HJ(2019).The anti-obesity effects of Tongbi-san in a high-fat diet-induced obese mouse model.BMC Complement Altern Med,19,1-14.
30. Perumpail, BJ,Li, AA,Iqbal, U(2018).Potential therapeutic benefits of herbs and supplements in patients with NAFLD.Diseases,6,1-19.
31. Poudyal, H,Campbell, F,Brown, L(2010).Olive leaf extract attenuates cardiac, hepatic, and metabolic changes in high carbohydrate-high fat-fed rats.J Nutr,140(5),946-953.
32. Ragab, SSM,Abd Elghaffar, SK,El-Metwally, TH,Badr, G,Mahmoud, MH,Omar, HM(2015).Effect of a high fat, high sucrose diet on the promotion of non-alcoholic fatty liver disease in male rats: the ameliorative role of three natural compounds.Lipids Health Dis,14(83),1-11.
33. Reznick, AZ,Packer, L(1994).Oxidative damage to proteins: spectrophotometric method for carbonyl assay.Methods Enzymol,233,357-363.
34. Rolo, AP,Teodoro, JS,Palmeira, CM(2012).Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis.Free Radic Biol Med,52,59-69.
35. Sasidharan, SR,Joseph, JA,Anandakumar, S,Venkatesan, V,Madhavan, CNA,Agarwal, A(2014).Ameliorative potential of Tamarindus indica on high fat diet induced nonalcoholic fatty liver disease in rats.Sci World J,2014,507197.
36. Schneider WC. Intracellular distribution of Enzymes III the oxidation of octanoic acid by rat liver fractions. J Biol Chem. 1948;176:259-266.
37. Shidfar, F,Moghayedi, M,Kerman, SRJ,Hosseini, S,Shidfar, S(2010).Effects of a calcium supplement on serum lipoproteins, apolipoprotein B, and blood pressure in overweight men.Int J Endocrinol Metab,8(4),194-200.
38. Shrager, S(2005).Dietary calcium intake and obesity.J Am Board Fam Pract,18,205-210.
39. Smith, BK,Marcinko, K,Desjardins, EM,Lally, JS,Ford, RJ,Steinberg, GR(2016).Treatment of nonalcoholic fatty liver disease: role of AMPK.Am J Physiol Endocrinol Metab,311,E730-E740.
40. Soares, MJ,She-Ping-Delfos, WLC(2010).Postprandial energy metabolism in the regulation of body weight: is there a mechanistic role for dietary calcium?.Nutrients,2,586-598.
41. Souza-Mello, V(2015).Peroxisome proliferator-activated receptors as targets to treat non-alcoholic fatty liver disease.World J Hepatol,7(8),1012-1019.
42. Stankovic, MN,Mladenovic, DR,Duricic, I(2014).Time-dependent changes and association between liver free fatty acids, serum lipid profile and histological features in mice model of nonalcoholic fatty liver disease.Arch Med Res,45,116-124.
43. Steinberg, GR,Kemp, BE(2009).AMPK in health and disease.Physiol Rev,89,1025-1078.
44. Than, NN,Newsome, PN(2015).A concise review of non-alcoholic fatty liver disease.Atherosclerosis,239,192-202.
45. Tsujita, T,Takaichi, H,Takaku, T,Aoyama, S,Hiraket, J(2006).Antiobesity action of epsilon-polysine, a potent inhibitor of pancreatic lipase.J Lipid Res,47,1852-1858.
46. Vidal-Puig, A,Jimenez-Liñan, M,Lowell, BB(1996).Regulation of PPAR gamma gene expression by nutrition and obesity in rodents.Eur J Clin Investig,97,2553-2561.
47. Wan, S,Zhang, L,Quan, Y,Wei, K(2018).Resveratrol-loaded PLGA nanoparticles: enhanced stability, solubility and bioactivity of resveratrol for non-alcoholic fatty liver disease therapy.R. Soc. open sci,5(11),181457.
48. Woo, MN,Bok, SH,Lee, MK(2008).Anti-obesity hypolipidemic effects of a proprietary herb fiber combination (S&S PWH) in rats fed high-fat diets.J Med Food,11,169-178.
49. Xavier, HT,Izar, MC,Faria Neto, JR(2013).Diretriz Brasileria de dislipidemia e prevenção da aterosclerose.Arq Bras Cardiol,101,1-20.
50. Zemel, M(2002).Regulation of adiposity and obesity risk by dietary calcium: mechanisms and implications.J Am Coll Nutr,21,146S-151S.
51. Zemel, M(2003).Mechanisms of dairy modulation of adiposity.J Nutr.,133,252S-256S.
52. Zemel, MB,Sun, X(2008).Dietary calcium and dairy products modulate oxidative and inflammatory stress in mice and humans.J Nutr.,138,1047-1052.
53. Zobeiri, M,Belwal, T,Parvizi, F(2018).Naringenin and its nano-formulations for fatty liver: cellular modes of action and clinical perspective.Curr Pharmaceut Biotechnol,19,196-205.